Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Dapagliflozin on Exercise and Cardiac Functional Status of Patients After Fontan Procedure

NCT07482943 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT07482943
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07482943 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Dapagliflozin on Exercise and Cardiac Functional Status of Patients After Fontan Procedure
Lead sponsor
The University of Hong Kong
Phase
Phase 4
Overall status
Recruiting
Start date
July 1, 2026
Completion date
July 31, 2028
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, dapagliflozin, fontan, heart failure, sodium-glucose cotransporter-2 inhibitors